GAMBAZZA, SIMONE
GAMBAZZA, SIMONE
Dipartimento di Scienze Cliniche e di Comunità
Perceived burden of respiratory physiotherapy in people with cystic fibrosis taking elexacaftor–tezacaftor–ivacaftor combination: a 1-year observational study
2024 C. Blardone, S. Gambazza, A. Mariani, R. Galgani, A. Brivio, R.M. Nobili, C. Rizza, A.L. Tutino, A. Gramegna, V. Daccò, M. Contarini, F. Blasi, D. Laquintana
Short‐term effects of positive expiratory pressure mask on ventilation inhomogeneity in children with cystic fibrosis: A randomized, sham‐controlled crossover study
2024 S. Gambazza, A. Mariani, R. Guarise, B. Ferrari, F. Carta, A. Brivio, S. Bizzarri, C. Castellani, C. Colombo, D. Laquintana
Evidence-informed and consensus-based statements about SAFEty of Physical Agent Modalities Practice in physiotherapy and rehabilitation medicine (SAFE PAMP): a national Delphi of healthcare scientific societies
2024 S. Gianola, S. Bargeri, L. Pellicciari, S. Gambazza, G. Rossettini, A. Fulvio, V. Genovese, M. Benedini, E. Proverbio, S. Cecchetto, G. Castellini, A. Turolla
Effectiveness of lumacaftor/ivacaftor initiation in children with cystic fibrosis aged 2 through 5 years on disease progression: Interim results from an ongoing registry-based study
2024 C. Kim, M. Higgins, L. Liu, N. Volkova, A. Zolin, L. Naehrlich, A. Pfleger, E. Lammertijn, D. Tješić-Drinković, P. Dřevínek, M.J. Macek, H. Vebert Olesen, N. Senecal, P.-. Burgel, G. Fletcher, R. Padoan, A. Orenti, F. Ambrogi, S. Gambazza, E. Aleksejeva, A.-. Charatsi, D. Zomer, E. Bakkeheim, L. Woźniacki, U. Krivec, C. Krantz, A. Lindblad, A. Jung, S. Clarke, S.B. Carr
Feasibility of high-frequency percussions in people with severe acquired brain injury and tracheostomy: an observational study
2024 S.A. Sciurello, F. Graziano, M.M. Laganà, E. Compalati, G. Pappacoda, S. Gambazza, J. Navarro, P. Cecconi, F. Baglio, P. Banfi
Stressful life events and accelerated biological aging over time in youths
2023 J.A. Sumner, X. Gao, S. Gambazza, C.K. Dye, N.L. Colich, A.A. Baccarelli, M. Uddin, K.A. Mclaughlin
A MULTI-STATE MODEL EVALUATING THE ASSOCIATION OF OXYGEN THERAPY WITH THE COURSE OF CYSTIC FIBROSIS IN EUROPE
2023 S. Gambazza, A. Orenti, A. Zolin, F. Ambrogi
Adherence to inhaled antibiotics in people with cystic fibrosis: insights from a virtual patient advisory board
2023 S. Gambazza, V. Storms, V. Purohit
Using electrical impedance tomography to characterize lung impairment of children with primary ciliary dyskinesia: A pilot cross-sectional study
2023 M. Pensabene, S. Gambazza, F. Carta, A. Rocchi, M. Lelii, B. Madini, V. Hassan, M. Piotto, M.F. Patria
Association of Oxygen Therapy with the Natural Disease Progression of Cystic Fibrosis: A Multi-State Model of the European Cystic Fibrosis Society Patient Registry
2023 S. Gambazza, A. Orenti, G. Pizzamiglio, A. Zolin, C. Colombo, D. Laquintana, F. Ambrogi
Setting up and managing the largest COVID-19 mass vaccination center in Lombardy, Italy
2023 J.G. Calegari, A. Bisesti, S. Pazzaglia, S. Gambazza, F. Binda, M. Bruno, L. Chiappa, A. Piatti, N. Tiwana, M. Letzgus, S. Castaldi, M. Sottocorno, D. Laquintana
The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours
2023 C. Resteghini, P. Castelnuovo, P. Nicolai, E. Orlandi, P. Bossi, B. Vischioni, A. Schreiber, S. Gambazza, N.A. Iacovelli, P. Battaglia, M. Guzzo, M. Turri-Zanoni, D. Mattavelli, N. Facchinetti, G. Calareso, M. Ravanelli, C. Facco, T. Tartaro, L. Licitra
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours
2023 P. Bossi, E. Orlandi, C. Resteghini, B. Vischioni, P. Nicolai, P. Castelnuovo, S. Gambazza, L.D. Locati, M. Turri-Zanoni, M. Ferrari, N. Facchinetti, N.A. Iacovelli, G. Calareso, P. Quattrone, A. Cavallo, A. Tuzi, L. Licitra
Pressure ulcers after prone positioning in patients undergoing extracorporeal membrane oxygenation: A cross-sectional study
2023 F. Binda, F. Marelli, A. Galazzi, S. Gambazza, E. Vinci, P. Roselli, I. Adamini, D. Laquintana
Extracellular Vesicle-Encapsulated microRNAs as Novel Biomarkers of Lung Health
2023 C.M. Eckhardt, S. Gambazza, T.R. Bloomquist, P. De Hoff, A. Vuppala, P.S. Vokonas, A.A. Litonjua, D. Sparrow, F. Parvez, L.C. Laurent, J. Schwartz, A.A. Baccarelli, H. Wu
Use of Musical Intervention in the Pediatric Intensive Care Unit of a Developing Country: A Pilot Pre–Post Study
2022 F. Buzzi, N. Bakir Yahya, S. Gambazza, F. Binda, A. Galazzi, A. Ferrari, S. Crespan, H. Adel Al-Atroushy, B. Maria Cantoni, D. Laquintana, C. Group
Association of ventilator-free days with respiratory physiotherapy in critically ill patients with Coronavirus Disease 2019 (COVID-19) during the first pandemic wave. A propensity score-weighted analysis
2022 E. Privitera, S. Gambazza, V. Rossi, M. Santambrogio, F. Binda, D. Tarello, S. Caiffa, V. Turrin, C. Casagrande, D. Battaglini, M. Panigada, R. Fumagalli, P. Pelosi, G. Grasselli
Lung clearance index to characterize clinical phenotypes of children and adolescents with cystic fibrosis
2022 S. Gambazza, F. Ambrogi, F. Carta, L. Moroni, M. Russo, A. Brivio, C. Colombo
The end of life of patients with COVID ‐19 in intensive care unit and the stress level on their family members: A cross‐sectional study
2022 A. Galazzi, F. Binda, S. Gambazza, F. Cantù, E. Colombo, I. Adamini, G. Grasselli, M. Lusignani, D. Laquintana, L. Rasero
Limitations of the dichotomized 6-minute walk distance when computing lung allocation score for cystic fibrosis: a 16-year retrospective cohort study
2022 S. Gambazza, F. Carta, F. Ambrogi, G. Bassotti, A. Brivio, M. Russo, C. Colombo